97 related articles for article (PubMed ID: 20817651)
21. [The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma].
Zhang H; Feng Z; Zhang G
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):416-8. PubMed ID: 11776614
[TBL] [Abstract][Full Text] [Related]
22. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
[TBL] [Abstract][Full Text] [Related]
23. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
24. Synergic influence of Ukrain and protoporphyrin amino acid conjugates on human malignant cell lines.
Brzosko WJ; Graczyk A; Konarski J; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):193-4. PubMed ID: 8899329
[TBL] [Abstract][Full Text] [Related]
25. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
26. The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin.
Berezhnaya NM; Vinnichuk YD; Belova OB
Exp Oncol; 2008 Mar; 30(1):52-5. PubMed ID: 18438341
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of murine melanoma with bryostatin 1.
Schuchter LM; Esa AH; May S; Laulis MK; Pettit GR; Hess AD
Cancer Res; 1991 Jan; 51(2):682-7. PubMed ID: 1985785
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
Winkelhake JL; Stampfl S; Zimmerman RJ
Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
[TBL] [Abstract][Full Text] [Related]
29. [Effect of histamine on metastasis of melanoma B16 cell xenograft in C57BL/6 mice].
Qin YS; Zhang X; Li L; Yu HL
Ai Zheng; 2007 Aug; 26(8):833-6. PubMed ID: 17697542
[TBL] [Abstract][Full Text] [Related]
30. Ukrain monotherapy in malignant melanoma (case report).
Hamler F; Hiesmayr W; Korsh O; Melnyk A
Drugs Exp Clin Res; 1996; 22(3-5):235-7. PubMed ID: 8899338
[TBL] [Abstract][Full Text] [Related]
31. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Björkdahl O; Dohlsten M; Sjögren HO
Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
[TBL] [Abstract][Full Text] [Related]
32. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
Sunkara PS; Bowlin TL; Rosenberger AL; Fleischmann WR
J Biol Response Mod; 1989 Apr; 8(2):170-9. PubMed ID: 2499664
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
34. Vasostatin increases oxygenation of B16-F10 melanoma tumors and raises therapeutic efficacy of cyclophosphamide.
Cichoń T; Jarosz M; Smolarczyk R; Ogórek B; Matuszczak S; Wagner M; Mitrus I; Sochanik A; Jazowiecka-Rakus J; Szala S
Acta Biochim Pol; 2012; 59(3):377-81. PubMed ID: 22946026
[TBL] [Abstract][Full Text] [Related]
35. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
Liepins A; Nowicky JW; Bustamante JO; Lam E
Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308
[TBL] [Abstract][Full Text] [Related]
36. Ukrain with chemotherapy in malignant melanoma (case report).
Stabuc B; Benedicic D
Drugs Exp Clin Res; 1996; 22(3-5):231-3. PubMed ID: 8899337
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
[TBL] [Abstract][Full Text] [Related]
38. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo.
Jin JL; Gong J; Yin TJ; Lu YJ; Xia JJ; Xie YY; Di Y; He L; Guo JL; Sun J; Noteborn MH; Qu S
Eur J Pharmacol; 2011 Mar; 654(1):17-25. PubMed ID: 21184754
[TBL] [Abstract][Full Text] [Related]
39. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.
Feleszko W; Lasek W; Gołab J; Jakóbisiak M
Neoplasma; 1995; 42(2):69-74. PubMed ID: 7617079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]